Neuroisualization of Pharmaco-EEG Effects of Leutragine by Normalized Cat Brain Electrograms
The central mechanisms of leutragine during inhalational administration were investigated by analyzing normalized brain cat electrograms obtained by the method of Fast Fourier Transform (FFT). According to the conducted pharmaco-electroencephalography (pharmaco-EEG) analysis, Leutragine demonstrates a maximum effect on the parameters of brain electrograms approximately 30 minutes after administration followed by its persistence for about 2 hours. The observed effect is characterized predominantly by a deprimation of all analyzed rhythms compared to the initial values. Normalized brain electrograms (NBE) are less pronounced in the area of the hippocampus, although being more pronounced in the area of the cingulate gyrus and posterior hypothalamus. This may indicate the leucinencephaline regulation of intracentral relations of the brain. The most significant effects obtained in high-frequency β- and γ-rhythms (about 20–25, 40 and 60 Hz) indicate an increase in the γ-activity of interneurons and inhibition of pyramidal cells, which may indicate an anti-anxiety, antidepressant, antiepileptic, analgesic and similar actions of the substance under study. The NBE parameters were found to identical under the action of Leutragine and the derivatives of gamma-aminobutyric acid (glutamine, gabapentin, pregabalin, and phenibut), mainly at frequencies of about 40 and 60 Hz. Similar NBE parameters were obtained under the action of nootropics (semax), which is expressed in the activation of the hippocampus and the hypothalamus posterior at frequencies of about 60–65 Hz. This suggests that the action of Leutragine reflects the mechanisms of GABAergic modulation of the hippocampus and prefrontal neocortex, at the same time as having a positive effect on mental performance, memory consolidation and cognitive function. Leutragine can be used to model and study mechanisms exhibiting a positive effect in the treatment of diseases caused, among other things, by the new coronavirus infection COVID-19.